Acadia Healthcare Company (ACHC) Cash from Investing Activities (2016 - 2025)
Acadia Healthcare Company (ACHC) has disclosed Cash from Investing Activities for 16 consecutive years, with -$92.4 million as the latest value for Q4 2025.
- On a quarterly basis, Cash from Investing Activities rose 54.54% to -$92.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$556.2 million, a 24.48% increase, with the full-year FY2025 number at -$556.2 million, up 24.48% from a year prior.
- Cash from Investing Activities was -$92.4 million for Q4 2025 at Acadia Healthcare Company, up from -$129.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.4 billion in Q1 2021 to a low of -$230.0 million in Q4 2021.
- A 5-year average of -$49.1 million and a median of -$101.3 million in 2023 define the central range for Cash from Investing Activities.
- Biggest YoY gain for Cash from Investing Activities was 1944.1% in 2021; the steepest drop was 704.68% in 2021.
- Acadia Healthcare Company's Cash from Investing Activities stood at -$230.0 million in 2021, then surged by 59.99% to -$92.0 million in 2022, then fell by 19.72% to -$110.2 million in 2023, then plummeted by 84.56% to -$203.3 million in 2024, then surged by 54.54% to -$92.4 million in 2025.
- Per Business Quant, the three most recent readings for ACHC's Cash from Investing Activities are -$92.4 million (Q4 2025), -$129.8 million (Q3 2025), and -$150.8 million (Q2 2025).